Login
Login

APHRC Online Microdata Library
  • Home
  • About APHRC
  • Datasets
  • Collections
  • Citations
  • Resources
  • How to use it?
  • Why sharing data?
  • Contact us
    Home / Central Data Catalog / HEALTH_AND_WELL-BEING / APHRC-SCALEUP-2014-1.0 / variable [F4]
Health_and_Well-Being

Sustainable model for Cardiovascular health by Adjusting Lifestyle and treatment with Economic perspective in settings of Urban Poverty, A community-based intervention for primary prevention of cardiovascular diseases in the slums of Nairobi

KENYA, 2012 - 2014
Health and Well-Being (HaW)
African Population and Health Research Center
Last modified March 03, 2017 Page views 357127 Documentation in PDF Metadata DDI/XML JSON
  • Study description
  • Documentation
  • Data Description
  • Get Microdata
  • Related Publications
  • Data files
  • Clinic_baseline
  • First_clinic
  • Followup_clinic
  • Population_baseline
  • Population_endline
  • Clinic_endline
CSV JSON

General comments (comments)

Data file: First_clinic

Overview

vald 692
Interval discrete

Questions and instructions

Categories
Value Category
5-10% has history of blood pressure started on HCTZ 25mg OD
5-10% - RISK PREDICTION
5-10%- LOW RISK PREDICTION
<5% RISK PREDICTION
> 30%
>10-20% stage I
>30% RISK PREDICTION
ADVICE TO VISIT THE KARIOBANGI CLINIC
ADVICED ON CUTTING DOWN WEIGHT
ADVICED ON LIFESTYLE CHANGE RISK PREDICTION >10-20%
ADVICED ON LIFESTYLE MODIFICATION
ADVICED ON WEIGHT REDUCTION
ADVICED TO CONTINUE COLLECTING INSULIN AT KARIOBANGI
AGE 62 YRS. RISK PREDICTION >20%
AGE 63 WAS ON HCTZ CT HCTZ
AGE GREATER THAN OR EQUAL TO60 YEARS, RISK PREDICTION - MODERATE >10-20%. KNOWN ASTHMATIC. SYSTOLIC >160
AGE NOT IN THE CHART
Advised on lifestyle change . Risk predicton moderate >10-20%
CLIENT FOLLOWED UP AT KNH FOR DM AND HYPERTENSION. SHE PREFERS TO CONTINUE TREATMENT FOR THE SAME AT KENYATTA. SHE HAS NO PROBLEM WITH TREATMENT COST.
CLIENT WENT HOME TO BRING THE PREMEDICATION DRUGS BUT THE CLINIC WAS CLOSED BEFORE HE RETURNED
COMPLAINS OF HEADACHE AND DIZZINESS
D.O.B during independence??? Risk prediction>10-20% Stage 2 HTW.
DIABETIC
Dm only: Also known asthmatic.
FASTING BLOOD SUGAR 9.2
HAS HISTORY OF BLOOD PRESSURE. ON NIFEDIPINE 20MG, ENALAPRIL 5MG RISK PREDICTION 5-10%
HIGH >20-20%
HIGH >30%
HIGH >30% II HYPERTENSION
HIGH PREDICTION > 30%
HIGH PREDICTION >30%
HIGH PREDICTION >30%
HIGH RISK >20-20%
HIGH RISK >30%
HIGH RISK PREDICTION 20-20%
HIGH RISK PREDICTION >30%
HTN STAGE II RISK PREDICTION >20-20%
HYPER TENSION STAGE II RISK PREDICTION MODERATE >10-20%
HYPERTENSION STAGE II >10-20%
HYPERTENSION STAGE II RISK PREDICTION-MODERATE
HYPERTENSIVE STAGE II RISK PREDICTION LOW 5-10%, BEGIN MEDS
High prediction > 20-20%
High, greater than 30%
II HYPERTENSIVE
Know diabetic, measured from Hospice
LOW <5%
LOW PREDICTION 5-10%
LOW PREDICTION 5-10%
LOW PREDICTION <5%
LOW RISK <5-10% + DIABETIC
LOW RISK<5%
MODERATE >10-20%
MODERATE >10-20%
MODERATE PREDICTION >10-20%
MODERATE PREDICTION 10-20%
MODERATE PREDICTION > 10-20%
MODERATE PREDICTION >10-20%
MODERATE PREDICTION: 10-20%
MODERATE PREDITION >10-20%
MODERATE RISK PREDICTION
MODERATE RISK PREDICTION >10-20%
MODERATE>10-20%
MONITOR BLOOD GLUCOSE. FBS RECOMMENDED NEXT VISIT. RISK PREDICTION HIGH >30%
NO DRUGS
NO DRUGS ISSUED
NON SMOKER,TAKES ALCOHOL.RISK PREDICTION LOW <5%.hYPERTENSIVE STAGE II
NONE
NONE HYPERTENSIVE FOR REVIEW ON 3/11/2012. RISK PREDICTION 5-10%
No chart
No chart;
PATIENTS HAS DRUGS FOR 1/12 WAS SEEN AT ST MARYS LANGATA. RISK >20-20% BUT ON STAGE REVIEW 1/12
REFERRED TO CONTINUE WITH KARIOBANGI CLINIC
RISK 10-20%
RISK 10-20% DIETARY CONTROL/ BEHAVIORAL CONTROL
RISK 20%
RISK 20% HAS BEEN ON ENALAPRIL
RISK 20% LIFESTYLE & HCTZ
RISK 30% ON RX
RISK 5-10%
RISK 5-10% LIFESTYLE ADJUSTMENT
RISK 5-10% PT HAS BEEN ON HTN ENALAPRIL,HCTZ
RISK 5-10% LIFESTYLE ADJUSTMENT
RISK 5-10% LOW LIFESTYLE ADJUSTMENT
RISK 5-10% ON ANTI HTN LIFESTYLE ADJUSTMENT
RISK 5-10% STAGE 1LIFESTYLE ADJUSTMENT
RISK <5% LIFESTYLE ADJUSTMENT
RISK > 10-20% PT IS ON ENALAPRIL, HCTZ AND METFOEMIN
RISK >10-20% STAGE I HTN
RISK >10-20% STAGE I
RISK >10-20% STAGE I HTN LIFESTYLE ADJUSTMENT
RISK >20%
RISK >20% DIABETIC N HTN
RISK >20-20%
RISK >30%
RISK >30% STAGE II
RISK ABOVE 30%
RISK FACTOR >10-20%
RISK FACTOR HIGH >20-30%
RISK PRDICCTION <5%
RISK PREDICION >30%
RISK PREDICTION
RISK PREDICTION 10-20% STAGE I HTN
RISK PREDICTION 10-20% STAGE II HTN
RISK PREDICTION >10-20%
RISK PREDICTION >10-20% LIFESTYLE CHANGE WITH REVIEW AFTER 3MONTH
RISK PREDICTION >10-20% MODERATE
RISK PREDICTION >20%
RISK PREDICTION >5%
RISK PREDICTION >5%. STAGE I HTN
RISK PREDICTION MODERATE >10-20%
RISK PREDICTION 5 – 10% NO DRUGS
RISK PREDICTION 5-10% STAGE I HTN LIFESTYLE ADJUSTMENT
RISK PREDICTION >10-20%
RISK PREDICTION >20%
RISK PREDICTION HIGH >20-20% HTN STAGE II
RISK PREDICTION - <5%
RISK PREDICTION - >10-20% (MODERATE)
RISK PREDICTION - LOW <5%
RISK PREDICTION - NOT POSSIBLE BECAUSE OF THE AGE 84YEARS
RISK PREDICTION ->10-20% NO DRUGS ISSUED
RISK PREDICTION 10-20% LIFESTYLE ADJUSTMENT
RISK PREDICTION 10-20% STAGE I HYPERTENSION
RISK PREDICTION 10-20% LIFESTYLE ADJUSTMENT
RISK PREDICTION 10-20%. START LIFESTYLE MODIFICATION
RISK PREDICTION 20-20%
RISK PREDICTION 5%-10%
RISK PREDICTION 5-10%
RISK PREDICTION 5-10% LIFESTYLE ADJUSTMENT
RISK PREDICTION 5-10% NO DRUGS ISSUED
RISK PREDICTION 5-10% STAGE I HTN
RISK PREDICTION 5-10% STAGE I HTN PLAN LIFESTYLE ADJUSTMENT
RISK PREDICTION 5-10% STARTED ON TREATMENT ADVICED ON LIFESTYLE CHANGE
RISK PREDICTION 5-10% CLIENT HAS NO COMPLAIN RELATED TO DM
RISK PREDICTION 5-10% STAGE HTN LIFESTYLE ADJ
RISK PREDICTION 5-10% STAGE I HTN LIFESTYLE ADJUSTMENT
RISK PREDICTION 5-10% STAGE II HTN LIFESTYLE ADJUSTMENT
RISK PREDICTION 5-10%, (HTN STAGE II)
RISK PREDICTION < 5%
RISK PREDICTION <20%
RISK PREDICTION <5 NO DRUGS ISSUED
RISK PREDICTION <5%
RISK PREDICTION <5% NO DRUGS
RISK PREDICTION <5% NO DRUGS ISSUED
RISK PREDICTION <5% NO DRUGS ISSUEID
RISK PREDICTION <5% REQUEST FIRST TO CONTINUE WITH LIFESTYLE
RISK PREDICTION <5%. HTN STAGE I
RISK PREDICTION <5%. HTN STAGE II
RISK PREDICTION > 10- 20%
RISK PREDICTION > 10-20%
RISK PREDICTION > 20%
RISK PREDICTION > 30%
RISK PREDICTION >10% -20% (MODERATE). CLIENT HAS BEEN ON LASIX. CLIENT SUFFERED STROKE 2010 DEC
RISK PREDICTION >10%-20%
RISK PREDICTION >10%-20% NO DRUGS ISSUED
RISK PREDICTION >10%-20% (MODERATE) NO DRUGS ISSUED
RISK PREDICTION >10%-20% NO DRUGS ISSUED
RISK PREDICTION >10-20%
RISK PREDICTION >10-20% NO DRUGS
RISK PREDICTION >10-20% NO DRUGS ISSUED
RISK PREDICTION >10-20% STAGE II HTN
RISK PREDICTION >10-20% STAGE II HYPERTENSION
RISK PREDICTION >10-20% ADVISED ON LIFESTYLE
RISK PREDICTION >10-20% MODERATE
RISK PREDICTION >10-20% NO DRUGS
RISK PREDICTION >10-20% NO DRUGS ISSUED
RISK PREDICTION >10-20% STAGE I HTN LIFESTYLE ADJUSTMENT
RISK PREDICTION >10-20% STAGE I HTN LIFESTYLE ADJUSTMENT
RISK PREDICTION >10-20%. HTN STAGE 2
RISK PREDICTION >10-20%. STAGE II
RISK PREDICTION >20%
RISK PREDICTION >20% ADVICED TO COME WITH OTHER MEDICATION SHE IS TAKING DURING THE NEXT VISIT
RISK PREDICTION >20% AGE IS 70 YEARS
RISK PREDICTION >20% ENCOURAGED TO BRING THE DRUGS SHE IS ON IN NEXT VISIT OF 03/10/12
RISK PREDICTION >20% DIABETIC
RISK PREDICTION >20% STAGE I HTN
RISK PREDICTION >20-20%
RISK PREDICTION >20-20% HTN II
RISK PREDICTION >20-20% KNOWN HYPERTENSIVE AND ON NIFEDIPINE
RISK PREDICTION >20-20%, PATIENT IS 83YEARS OLD
RISK PREDICTION >30%
RISK PREDICTION >30% PT IS ON HYPERTENSIVES
RISK PREDICTION >30% STAGE II HTN
RISK PREDICTION >30% STAGE II HYPERTENSION
RISK PREDICTION >30% HTN STAGE II
RISK PREDICTION >30% STAGE II HTN
RISK PREDICTION >30%. BEGIN MEDS AND LIFESTYLE MODIFICATION. MONITOR RBS CLOSELY
RISK PREDICTION >5%
RISK PREDICTION >5-10%
RISK PREDICTION ABOVE 30%
RISK PREDICTION ABOVE CHART ESTIMATE PLAN START HCTZ STAGE II HTN
RISK PREDICTION HIGH
RISK PREDICTION HIGH (20-30%). BEGIN MEDS + LIFESTYLE MODIFICATION, REVIEW AFTER ONE MONTH
RISK PREDICTION HIGH 20-20%
RISK PREDICTION HIGH 20-30%. STAGE I HYPERTENSION. START LIFESTYLE MODIFICATION + MEDS
RISK PREDICTION HIGH 20-30%. START MEDS + LIFESTYLE MODIFICATION. FOR FBS NEXT VISIT
RISK PREDICTION HIGH > 20% IN STAGE II HYPERTENSION
RISK PREDICTION HIGH >20% STAGE I HYPERTENSION
RISK PREDICTION HIGH >20-20%
RISK PREDICTION HIGH >20-30%
RISK PREDICTION HIGH >20-30% STAGE I HYPERTENSION
RISK PREDICTION HIGH >20-30%. START LIFESTYLE MODIFICATION + MEDS. MONITOR RBG CLOSELY IF NO CHANGE ADD METFORMIN
RISK PREDICTION HIGH >30%
RISK PREDICTION HIGH >30%. STAGE I HYPERTENSION. START MEDS
RISK PREDICTION LOW 5-10%
RISK PREDICTION LOW 5-10%
RISK PREDICTION LOW 5-10%. BEGIN LIFESTYLE MODIFICATION. REVIEW AFTER 1MONTH
RISK PREDICTION LOW 5-10%. NOT ENROLLED SHE IS BELOW 35YRS.
RISK PREDICTION LOW 5-10%. NOT ENROLLED SHE'S BELOW 35YRS
RISK PREDICTION LOW 5-10%. TO BEGIN LIFESTYLE MODIFICATION
RISK PREDICTION LOW <5%
RISK PREDICTION LOW <5%. BEGIN LIFESTYLE MODIFICATION
RISK PREDICTION LOW <5%. CT LIFESTYLE MODIFIDICATION
RISK PREDICTION LOW <5-10%,ADVICED ON LIFESTYLE MODIFICATION
RISK PREDICTION LOW<5%
RISK PREDICTION MODERATE 10-20%
RISK PREDICTION MODERATE 10-20% STAGE II HYPERTENSION
RISK PREDICTION MODERATE 10-20%. WITH ISOLATED SYSTOLIC HYPERTEENSION
RISK PREDICTION MODERATE 10-20%. CT ANTIDIABETICS
RISK PREDICTION MODERATE 10-20%. MONITOR BP CLOSELY IFNO CHANGE AFTER 3 MONTHS START MEDS. TARGET BP IN DM IS <130/80mmHg
RISK PREDICTION MODERATE 10-20%. STAGE I HYPERTENSION.
RISK PREDICTION MODERATE 10-20%. STAGE I HYPERTENSION. START LIFESTYLE MODIFICATION.
RISK PREDICTION MODERATE 10-20%. STAGE II HYPERTENSION.
RISK PREDICTION MODERATE 5-10%. START LIFESTYLE MODIFICATION
RISK PREDICTION MODERATE <10-20%. BEGIN LIFESTYLE MODIFICATION
RISK PREDICTION MODERATE >10-20%
RISK PREDICTION MODERATE >10-20% ADVICE ON LIFESTYLE ADJUSTMENT AND MONTHLY FOLLOWUP
RISK PREDICTION MODERATE >10-20%. START LIFESTYLE MODIFICATION
RISK PREDICTION MOODERATE >10_20% NO DRUGS ISSUED
RISK PREDICTION – LOW 5 -10% HYPERTENSION 2nd DEGREE TO THYROTOXICOSIS
RISK PREDICTION: MODERATE 5-10% ADVISED ON LIFESTYLE ADJUSTMENT & ADHERENCE COUNSELLING
RISK PREDICTION<5%
RISK PREDICTION>10-20%
RISK PREDICTION>20%
RISK PREDICTION>30%
RISK PREDICTION>30% STAGE II HTN
RISK PREDICTON >10-20%
RISK PREEDICTION 5-10%
RISK REDICTION >20-20%
RISK> 20% HCTZ 25mg OD*32/7
Risk prediction >30%
Risk > 20-20%
Risk prediction
Risk prediction mod >10-20% HTM TWO.
Risk prediction - >10% -20% (MODERATE) NO DRUGS ISSUED.
Risk prediction 20-30%.
Risk prediction 5%
Risk prediction 5-10%
Risk prediction 5-10% Stage 1 hypertension
Risk prediction > 10-20%
Risk prediction > 10-20% but patient was on meds before
Risk prediction >10-20%. No drugs issued.
Risk prediction >20%, Age 80 years, Cannot stand no measurements.
Risk prediction >5% lifestyle adjustment.
Risk prediction greater than 10-20%
Risk prediction high>20-30. start meds +lifesytle modification.
Risk prediction less than 5%
Risk prediction low 25% in stage II hypertension.
Risk prediction low (5-10). start lifesytle modification.
Risk prediction low 25%
Risk prediction low 5-10%
Risk prediction low <5-10% a follow -up kariobangi;
Risk prediction low<5% stage 1 hypertension
Risk prediction not able to calculate. Due to his age and BP 140, recommend to start Rx
Risk prediction- loe 5-10% Advised on lifesytle modification.
Risk prediction. >-20%.
Risk prediction<5%(low).
Risk prediction>30%.
SATGE II HYPERTENSION
SATGE II HYPERTENSION PATIENT REPORTED TO HAVE A HEART LESION BUT ABSCONDED CLINIC AT KNH NB: HIP AND WAIST MEASURES NOT TAKEN. SHE WAS NOT ABLE TO STAND
SEVERE HYPERTENSION - HEADACHE BLURRED VISION AGE-60 YEARS
SMOKER RISK PREDICTION >30%
STAGE 2 HYPERTENSION
STAGE I HYPERTENSION RISK PREDICTION LOW 5-10% START ON NIFEDIPINE REFFERED TO KARIOBANGI FOR FOLLOW UP
STAGE I HYPERTENSION RISK PREDICTION >30% START MEDS + LIFESTYLE ADJUSTMENT
STAGE I HYPERTENSION RISK PREDICTION >30%`
STAGE II HYPERTENSION
STAGE II HYPERTENSION NB: RESPONDENT CANNOT STAND BY HIS FEET
STAGE II HYPERTENSION RISK PREDICTION HIGH 20-30% START ANTIHYPERTENSIVE + LIFESTYLE MODIFICATION
STAGE II HYPERTENSION NB: PATIENT UNABLE TO STAND
STAGE II HYPERTENSION PREVIOUSLY SUFFERED NIFEDIPINE SIDE EFFECTS EFFECTS OF OEDEMA
STAGE II HYPERTENSION RISK 20% ALLERGIC TO ENALAPRIL (DRY COUGH)
STAGE II HYPERTENSION STARTED RX ON 21/11/2012
STAGE II HYPERTENSION TABS NIFEDIPINE 40MG START CHECK BP 171/81
STAGE II HYPERTENSION + DIABETES
STAGE II HYPERTENSION AND DIABETIES
STAGE II HYPERTENSION PLAIN LIFESTYLE ADJUSTMENT
STAGE II HYPERTENSION SEPARATED
STAGE II HYPERTENSION. CLIENT HAS NO HTN EMERGENCY SIGNS
STAGE II HYPERTENSION. RISK PREDICTION HIGH >20% LIFESTYLE MODIFICATION + MEDS
STAGE II HYPERTENSION.CLIENT DIDNT COME WITH DRUGS SHE IS ON SHE PREFERS TO CONTINUE WITH DRUGS SHE IS ON
STAGE II HYPERTENSIVE
START MEDS. RISK PREDICTION HIGH 20-30%; BUT TARGET BP OK
She has a histroy of hypertension Continue monitoring her BP
Stage I hypertension risk prediction greater than 20%
Stage II Hypertension.
Stage II hypertension
Stage II hypertension. Risk greater than 20-26%
Start RX Risk factor high due to age and BD NB/Respodent cannot stand.
To a Kariobangi clinic.
To be seen on 5th/4 for fashing blood sugar.
bp was too high could not be measured by BP machine
continue follow -up kARIOBANGI
hypertensive stage II risk prediction - moderate greater than 10-20%
low 5-10%
low less than 5% advised on lifestyle advised on change F/P method visit FP clinic
low prediction 5-10%
moderase >10-20%
moderate prediction 10-20%
moderate risk greater than 10-20%
moderate risk prediction
on follow-up at Kariobangi, to continue.
risk 10-20% lifestyle
risk 10-20% lifestyle adjustment
risk 20%
risk 20% lifestyle and HCTZ
risk 30%
risk 5-10%
risk 5-10% lifestyle adjustment
risk predcition > 30%
risk predcition less than 5%
risk predcition less than 5% no drugs issued
risk prediction (no chart) RBG reads high
risk prediction - moderate, greater than 10-20%
risk prediction - moderate,> 10-20% advised on lifestyle modification
risk prediction 10-20%
risk prediction 10-20% stage II HTN lifestyle
risk prediction 20-20%
risk prediction 5-10%
risk prediction 5-10% HTN Stage II
risk prediction 5-10% no drugs
risk prediction 5-10% no drugs issued
risk prediction 5-10% STG I HTN
risk prediction 5-10% low
risk prediction <5%
risk prediction > 10-20%
risk prediction > 20%
risk prediction >10-20%
risk prediction >20-20%
risk prediction >20-20% hypertension stage II
risk prediction >30%
risk prediction >30% hypertension stage II
risk prediction >30% patient is 75years old
risk prediction >5% stage I HTN
risk prediction >5-10%
risk prediction greater than 10-20%
risk prediction greater than 20%
risk prediction greater than 20-20%
risk prediction greater then 20-20% low BMI
risk prediction high 20-30% continue all meds
risk prediction high > 30%
risk prediction high > 30% Advised on lifestyle modification, meanwhile to start oral hypoglycaemics
risk prediction high >30%
risk prediction less than 5%
risk prediction low 5-10%
risk prediction low 5-10% stage II hypertension
risk prediction low < 5%
risk prediction low <5%
risk prediction low <5% hypertension stage II
risk prediction low <5% stage II hypertension
risk prediction moderate 10-20%
risk prediction moderate 20-20%
risk prediction moderate 20-30% stage I hypertension
risk prediction moderate >10%-20%
risk prediction- low: >5%
risk prediction-low 5-10%.
risk predictions 5-10%
riskprediction >10-20%
stage II HYPERTENSION
stage II hyoertension
stage II hypertension
stage II hypertension. risk prediction low 5%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
APHRC Microdata Portal

© APHRC Microdata Portal, All Rights Reserved. Slot Online